Sunday, 17 Nov, 2024

Health

Bangavax gets permission for human trial

Staff Correspondent | banglanews24.com
Update: 2022-07-17 18:42:23
Bangavax gets permission for human trial

The Department of Medicine Administration has allowed a clinical trial of the Bangvax vaccine in human body.

Globe Biotech Limited Senior Manager (Quality and Regulatory) Dr. Mohammad Mohiuddin confirmed this information to Banglanews on Sunday (July 17). 

“We got permission for the clinical trial of the vaccine...we will give further details regarding this later,” he said.

Bangvax vaccine developed by Globe Biotech proved to be safe and effective in pre-clinical trials in rabbits, rats and monkeys. 

On November 23, 2021, the local pharmaceutical company received Bangladesh Medical Research Council (BMRC) ethical permission to begin human trials of its single-dose Covid-19 vaccine "Bangavax."

BDST: 1842 HRS, JULY 17, 2022
MSK/SMS

All rights reserved. Sale, redistribution or reproduction of information/photos/illustrations/video/audio contents on this website in any form without prior permission from banglanews24.com are strictly prohibited and liable to legal action.